226 related articles for article (PubMed ID: 27464306)
21. Structure-based discovery of inhibitors of microsomal prostaglandin E2 synthase-1, 5-lipoxygenase and 5-lipoxygenase-activating protein: promising hits for the development of new anti-inflammatory agents.
De Simone R; Chini MG; Bruno I; Riccio R; Mueller D; Werz O; Bifulco G
J Med Chem; 2011 Mar; 54(6):1565-75. PubMed ID: 21323313
[TBL] [Abstract][Full Text] [Related]
22. A Combinatorial Virtual Screening Approach Driving the Synthesis of 2,4-Thiazolidinedione-Based Molecules as New Dual mPGES-1/5-LO Inhibitors.
Lauro G; Terracciano S; Cantone V; Ruggiero D; Fischer K; Pace S; Werz O; Bruno I; Bifulco G
ChemMedChem; 2020 Mar; 15(6):481-489. PubMed ID: 32022480
[TBL] [Abstract][Full Text] [Related]
23. Pharmacophore modeling and virtual screening for novel acidic inhibitors of microsomal prostaglandin E₂ synthase-1 (mPGES-1).
Waltenberger B; Wiechmann K; Bauer J; Markt P; Noha SM; Wolber G; Rollinger JM; Werz O; Schuster D; Stuppner H
J Med Chem; 2011 May; 54(9):3163-74. PubMed ID: 21466167
[TBL] [Abstract][Full Text] [Related]
24. Antinociceptive and anti-inflammatory potential of extract and isolated compounds from the leaves of Salvia officinalis in mice.
Rodrigues MR; Kanazawa LK; das Neves TL; da Silva CF; Horst H; Pizzolatti MG; Santos AR; Baggio CH; Werner MF
J Ethnopharmacol; 2012 Jan; 139(2):519-26. PubMed ID: 22154965
[TBL] [Abstract][Full Text] [Related]
25. Biological characterization of new inhibitors of microsomal PGE synthase-1 in preclinical models of inflammation and vascular tone.
Larsson K; Steinmetz J; Bergqvist F; Arefin S; Spahiu L; Wannberg J; Pawelzik SC; Morgenstern R; Stenberg P; Kublickiene K; Korotkova M; Jakobsson PJ
Br J Pharmacol; 2019 Dec; 176(24):4625-4638. PubMed ID: 31404942
[TBL] [Abstract][Full Text] [Related]
26. Rotational constriction of curcuminoids impacts 5-lipoxygenase and mPGES-1 inhibition and evokes a lipid mediator class switch in macrophages.
Rao Z; Caprioglio D; Gollowitzer A; Kretzer C; Imperio D; Collado JA; Waltl L; Lackner S; Appendino G; Muñoz E; Temml V; Werz O; Minassi A; Koeberle A
Biochem Pharmacol; 2022 Sep; 203():115202. PubMed ID: 35932797
[TBL] [Abstract][Full Text] [Related]
27. Investigations on anti-inflammatory and analgesic activities of Alnus nitida Spach (Endl). stem bark in Sprague Dawley rats.
Sajid M; Khan MR; Shah SA; Majid M; Ismail H; Maryam S; Batool R; Younis T
J Ethnopharmacol; 2017 Feb; 198():407-416. PubMed ID: 28119101
[TBL] [Abstract][Full Text] [Related]
28. Design and Development of Microsomal Prostaglandin E2 Synthase-1 Inhibitors: Challenges and Future Directions.
Koeberle A; Laufer SA; Werz O
J Med Chem; 2016 Jul; 59(13):5970-86. PubMed ID: 26791385
[TBL] [Abstract][Full Text] [Related]
29. A novel class of dual mPGES-1/5-LO inhibitors based on the α-naphthyl pirinixic acid scaffold.
Hieke M; Greiner C; Thieme TM; Schubert-Zsilavecz M; Werz O; Zettl H
Bioorg Med Chem Lett; 2011 Mar; 21(5):1329-33. PubMed ID: 21310608
[TBL] [Abstract][Full Text] [Related]
30. Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo.
Hanke T; Dehm F; Liening S; Popella SD; Maczewsky J; Pillong M; Kunze J; Weinigel C; Barz D; Kaiser A; Wurglics M; Lämmerhofer M; Schneider G; Sautebin L; Schubert-Zsilavecz M; Werz O
J Med Chem; 2013 Nov; 56(22):9031-44. PubMed ID: 24171493
[TBL] [Abstract][Full Text] [Related]
31. Natural products as inhibitors of prostaglandin E
Koeberle A; Werz O
Biotechnol Adv; 2018 Nov; 36(6):1709-1723. PubMed ID: 29454981
[TBL] [Abstract][Full Text] [Related]
32. Tetra- and pentacyclic triterpene acids from the ancient anti-inflammatory remedy frankincense as inhibitors of microsomal prostaglandin E(2) synthase-1.
Verhoff M; Seitz S; Paul M; Noha SM; Jauch J; Schuster D; Werz O
J Nat Prod; 2014 Jun; 77(6):1445-51. PubMed ID: 24844534
[TBL] [Abstract][Full Text] [Related]
33. Identification of 2-mercaptohexanoic acids as dual inhibitors of 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1.
Greiner C; Zettl H; Koeberle A; Pergola C; Northoff H; Schubert-Zsilavecz M; Werz O
Bioorg Med Chem; 2011 Jun; 19(11):3394-401. PubMed ID: 21570310
[TBL] [Abstract][Full Text] [Related]
34. Infusion of aerial parts of Salvia chudaei Batt. & Trab. from Algeria: Chemical, toxicological and bioactivities characterization.
Semaoui R; Ouafi S; Machado S; Barros L; Ferreira ICFR; Oliveira MBPP
J Ethnopharmacol; 2021 Nov; 280():114455. PubMed ID: 34320383
[TBL] [Abstract][Full Text] [Related]
35. Identification of multi-target inhibitors of leukotriene and prostaglandin E
Gür ZT; Çalışkan B; Garscha U; Olgaç A; Schubert US; Gerstmeier J; Werz O; Banoglu E
Eur J Med Chem; 2018 Apr; 150():876-899. PubMed ID: 29597170
[TBL] [Abstract][Full Text] [Related]
36. Ginkgolic Acid is a Multi-Target Inhibitor of Key Enzymes in Pro-Inflammatory Lipid Mediator Biosynthesis.
Gerstmeier J; Seegers J; Witt F; Waltenberger B; Temml V; Rollinger JM; Stuppner H; Koeberle A; Schuster D; Werz O
Front Pharmacol; 2019; 10():797. PubMed ID: 31379572
[No Abstract] [Full Text] [Related]
37. Design and synthesis of a second series of triazole-based compounds as potent dual mPGES-1 and 5-lipoxygenase inhibitors.
Chini MG; De Simone R; Bruno I; Riccio R; Dehm F; Weinigel C; Barz D; Werz O; Bifulco G
Eur J Med Chem; 2012 Aug; 54():311-23. PubMed ID: 22683242
[TBL] [Abstract][Full Text] [Related]
38. Topical analgesic, anti-inflammatory and antioxidant properties of Oxybaphus nyctagineus: phytochemical characterization of active fractions.
Könczöl Á; Engel R; Szabó K; Hornok K; Tóth S; Béni Z; Prechl A; Máthé I; Tibor Balogh G
J Ethnopharmacol; 2014 Aug; 155(1):776-84. PubMed ID: 24945398
[TBL] [Abstract][Full Text] [Related]
39. Central and peripheral pain intervention by Ophiorrhizarugosa leaves: Potential underlying mechanisms and insight into the role of pain modulators.
Uddin Chy MN; Adnan M; Chowdhury MR; Pagano E; Kamal ATMM; Oh KK; Cho DH; Capasso R
J Ethnopharmacol; 2021 Aug; 276():114182. PubMed ID: 33964360
[TBL] [Abstract][Full Text] [Related]
40. Structure-based screening for the discovery of 1,2,4-oxadiazoles as promising hits for the development of new anti-inflammatory agents interfering with eicosanoid biosynthesis pathways.
Potenza M; Sciarretta M; Chini MG; Saviano A; Maione F; D'Auria MV; De Marino S; Giordano A; Hofstetter RK; Festa C; Werz O; Bifulco G
Eur J Med Chem; 2021 Nov; 224():113693. PubMed ID: 34315041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
